DYNLT1: A Potential Drug Target Or Biomarker for Various Diseases

Target Name: DYNLT1

NCBI ID: G6993

DYNLT1

DYNLT1: A Potential Drug Target Or Biomarker for Various Diseases

DYNLT1 (TCTEX1) is a gene that has been identified as a potential drug target or biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique function and its potential to contribute to the development of new treatments for these diseases make it an intriguing target for researchers.

The DYNLT1 gene is located on chromosome 16 and encodes for a protein known as TCTEX1. This protein is involved in the development and maintenance of tissues that line the body, such as the skin, hair, and nails. It is also involved in cell signaling and has been shown to play a role in several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the most promising aspects of DYNLT1 is its potential as a drug target. Researchers have identified several potential drug compounds that can interact with the TCTEX1 protein and are currently in the process of testing these compounds for their efficacy in treating various diseases. These compounds have been shown to inhibit the activity of the TCTEX1 protein and reduce the growth of cancer cells.

In addition to its potential as a drug target, DYNLT1 has also been identified as a potential biomarker for several diseases. Its expression has been shown to be elevated in several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This suggests that DYNLT1 may be a useful indicator of the severity and progression of these diseases.

Furthermore, DYNLT1 has also been shown to be involved in several cellular processes that are important for the development and maintenance of tissues. It is involved in cell signaling, cell division, and cell migration. Its expression has also been shown to be regulated by several factors, including growth factors, cytokines, and chemokines.

Overall, DYNLT1 is a gene that has significant potential as a drug target or biomarker for several diseases. Its unique function and its involvement in several cellular processes make it an intriguing target for researchers. Further studies are needed to fully understand its role in the development and progression of these diseases and to develop effective treatments.

Protein Name: Dynein Light Chain Tctex-type 1

Functions: Acts as one of several non-catalytic accessory components of the cytoplasmic dynein 1 complex that are thought to be involved in linking dynein to cargos and to adapter proteins that regulate dynein function. Cytoplasmic dynein 1 acts as a motor for the intracellular retrograde motility of vesicles and organelles along microtubules. Binds to transport cargos and is involved in apical cargo transport such as rhodopsin-bearing vesicles in polarized epithelia. May also be a accessory component of axonemal dynein

The "DYNLT1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DYNLT1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets